Production at Biocon Biologics’ own facilities is scheduled to begin once technology transfers and regulatory approvals are finalized
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
The company also reported significant progress toward its internally defined Sustainable Development Goals
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
,_Thyrocare_256_384.jpg)
Dr Kinha is a seasoned healthcare and diagnostics leader with over 17 years of experience across leading organisations in the diagnostics sector, with deep expertise in laboratory operations and quality systems
The expansion includes a larger technical and service team and increased local procurement
India plays a critical role in Bristol Myers Squibb’s global strategy
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
Subscribe To Our Newsletter & Stay Updated
